Take One: Big story of the day
-
Inside MakeMyTrip's $3.1 billion shake-up
The online travel provider raised a record sum to reduce Trip.com's stake amid geopolitical tensions and allegations over Chinese links. The China-based platform says the sale aligns with its strategy to optimise its investment portfolio
-
WhatsApp and Amazon Prime Video aim to encash user attention
With rising competition and costs, the two ad-free platforms are now turning to a newer, more promising revenue stream
-
West Asia crisis: Is India insulated?
The closure of the critical oil corridor Strait of Hormuz will lead to a steep increase in oil prices affecting all countries as prices tend to be linked across markets
-
The million-dollar pitch: Who'll be the next iconic cricketing brand?
As legends like Virat Kohli and Rohit Sharma retire from Tests, the transition generation led by Shubman Gill will look to step into their shoes, both on and off the field
-
Startup IPOs get a Sebi fillip
Some of the reformative decisions taken under Sebi Chairman Tuhin Kanta Pandey will offer greater flexibility in employee stock option plans for founders, and relaxed rules around compulsorily convertible securities
-
What does the Ahmedabad crash mean for Air India's turnaround ambitions?
In the short term, the airline's market share will be affected. It will also force a review of all things internal and push back the airline's five-year growth plan
-
US Volatility: Is India insulated?
As US debt surges, bond yields spike, and Moody's downgrades its credit rating, analysts explain the possible impact on India
-
Will Yes Bank leapfrog led by Japan's SMBC investment?
In May, Sumitomo Mitsui Banking Corporation (SMBC), a Sumitomo Mitsui Financial Group subsidiary, announced plans to acquire a 20 percent stake in Yes Bank, making it the largest cross-border investment in an Indian bank. Analysts, however, say the bank needs to boost its asset mix and focus on accelerating profitability for real results
-
How India is reshaping global trade
The country's early engagement with the US on the bilateral deal may place it ahead of the pack in reducing trade tensions. And the FTA with the UK underlines a change in its policy approach—bilateral instead of regional trade agreements
-
Indian pharma catching up to Ozempic, Mounjaro demand
Indian market for these drugs has grown to nearly Rs 600 crore and is expected to keep growing. Weight-loss drugs are transforming India's health landscape. But without strong oversight, risks may outweigh rewards
-
How IndiGo is taking the fight to Air India's doorsteps
Few knew about IndiGo globally when former KLM CEO and president decided to take the reins in 2022. That is perhaps why, since he took charge, Pieter Elbers has turned much of the airline's attention to international operations